TI
SRPT icon

Turner Investments’s Sarepta Therapeutics SRPT Stock Holding History

Turner Investments’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-66,370
Closed -$1.98M – 571
2014
Q2 		$1.98M Sell
66,370
-5,460
-8% -$173K 0.09% 288
2014
Q1 		$1.73M Buy
+71,830
New +$1.83M 0.05% 367
2013
Q4 		– Sell
-206,760
Closed -$9.77M – 644
2013
Q3 		$9.77M Sell
206,760
-37,220
-15% -$1.43M 0.16% 194
2013
Q2 		$9.28M Buy
+243,980
New +$8.73M 0.12% 229

Other funds holding SRPT

CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Turner Investments's SRPT Position: Q3 2014 in Review

Turner Investments sold out of Sarepta Therapeutics (SRPT) in Q3 2014, closing a stake of 66,370 shares — an estimated $1.98M sold.

Turner Investments first reported a position in SRPT in Q2 2013 and held it in 4 quarters. The position peaked at $9.77M in Q3 2013. 123 funds tracked by Wall St. Rank hold SRPT as of Q3 2014.

  • Turner Investments reported no remaining Sarepta Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Turner Investments sold 66,370 Sarepta Therapeutics shares in Q3 2014, an estimated $1.98M.
  • Turner Investments first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 4 quarters.
  • Turner Investments's Sarepta Therapeutics position peaked at $9.77M in Q3 2013.
  • 123 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2014.

Based on Turner Investments's 13F filing for Q3 2014, filed 7 Nov 2014.